Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2009 2
2010 1
2013 1
2014 1
2015 1
2016 1
2020 1
2021 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hemolytic disease of fetus OR newborn due to isoimmunization"
Page 1
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP, Kaminski A, Tjoa ML, Oepkes D. de Winter DP, et al. BMC Pregnancy Childbirth. 2023 Jan 7;23(1):12. doi: 10.1186/s12884-022-05329-z. BMC Pregnancy Childbirth. 2023. PMID: 36611144 Free PMC article.
BACKGROUND: Prevention of pregnancy-related alloimmunization and the management of hemolytic disease of the fetus and newborn (HDFN) has significantly improved over the past decades. Considering improvements in HDFN care, the objectives of this systema …
BACKGROUND: Prevention of pregnancy-related alloimmunization and the management of hemolytic disease of the fetus and …
Mirror syndrome: a systematic literature review.
Biswas S, Gomez J, Horgan R, Sibai BM, Saad A, Powel JE, Al-Kouatly HB. Biswas S, et al. Am J Obstet Gynecol MFM. 2023 Sep;5(9):101067. doi: 10.1016/j.ajogmf.2023.101067. Epub 2023 Jun 28. Am J Obstet Gynecol MFM. 2023. PMID: 37385374 Review.
RESULTS: Of 13 citations, 12 studies (n=82) reported diagnostic criteria for mirror syndrome: maternal edema (11/12), fetal hydrops (9/12), placental edema (6/12), placentomegaly (5/12), and preeclampsia (2/12); 12 studies (n=82) described the clinical presentation of mirror synd …
RESULTS: Of 13 citations, 12 studies (n=82) reported diagnostic criteria for mirror syndrome: maternal edema (11/12), fetal hydrops (9/12), …
Misclassification of RhD variants among pregnant women: a systematic review.
Owaidah AY, Yamani LZ. Owaidah AY, et al. J Med Life. 2023 Jul;16(7):981-989. doi: 10.25122/jml-2023-0004. J Med Life. 2023. PMID: 37900088 Free PMC article. Review.
The D antigen of the Rh blood group is considered clinically significant due to its ability to cause hemolytic transfusion reactions and hemolytic disease in the fetus and newborn. ...
The D antigen of the Rh blood group is considered clinically significant due to its ability to cause hemolytic transfusion reactions …
Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
Louis D, More K, Oberoi S, Shah PS. Louis D, et al. Arch Dis Child Fetal Neonatal Ed. 2014 Jul;99(4):F325-31. doi: 10.1136/archdischild-2013-304878. Epub 2014 Feb 10. Arch Dis Child Fetal Neonatal Ed. 2014. PMID: 24514437 Review.
BACKGROUND: Intravenous immunoglobulin (IVIg) is used in neonates with isoimmune haemolytic disease to prevent exchange transfusion (ET). ...OBJECTIVE: To update the systematic review of efficacy and safety of IVIg in neonates with isoimmune haemoly
BACKGROUND: Intravenous immunoglobulin (IVIg) is used in neonates with isoimmune haemolytic disease to prevent exchange …
Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI, Afolabi BB. Okwundu CI, et al. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007885. doi: 10.1002/14651858.CD007885.pub2. Cochrane Database Syst Rev. 2013. PMID: 23440818 Review.
BACKGROUND: Antibodies to the red cell Rhesus D (RhD) antigen can be produced during pregnancy in a RhD-negative mother carrying a RhD-positive fetus, in particular following feto-maternal haemorrhage at birth or following any procedure that may cause feto-maternal haemorr …
BACKGROUND: Antibodies to the red cell Rhesus D (RhD) antigen can be produced during pregnancy in a RhD-negative mother carrying a RhD-posit …
Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.
Alshehri AA, Jackson DE. Alshehri AA, et al. Transfus Med Rev. 2021 Apr;35(2):85-94. doi: 10.1016/j.tmrv.2021.02.001. Epub 2021 Mar 1. Transfus Med Rev. 2021. PMID: 33781630 Review.
Hemolytic disease of fetus and newborn (HDFN) imposes great healthcare burden being associated with maternal alloimmunization against parental-inherited fetal red blood cell antigens causing fetal anemia or death. ...
Hemolytic disease of fetus and newborn (HDFN) imposes great healthcare burden being associated with maternal all
Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review.
Chen C, Tan J, Wang L, Han B, Sun W, Zhao L, Huang C, Tan B, Qin L. Chen C, et al. Transfusion. 2016 Apr;56(4):975-9. doi: 10.1111/trf.13430. Epub 2015 Dec 6. Transfusion. 2016. PMID: 26638180 Review.
BACKGROUND: Unexpected antibodies are frequently associated with hemolytic disease of the fetus and newborn (HDFN) and hemolytic transfusion reactions (HTRs), and screening for those unexpected antibodies is critical for the safety and effective …
BACKGROUND: Unexpected antibodies are frequently associated with hemolytic disease of the fetus and newborn (HDF …
Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS, Liley H. Alcock GS, et al. Cochrane Database Syst Rev. 2002;(3):CD003313. doi: 10.1002/14651858.CD003313. Cochrane Database Syst Rev. 2002. PMID: 12137687 Updated. Review.
OBJECTIVES: To assess whether the use of intravenous immunoglobulin, in newborn infants with isoimmune haemolytic jaundice, is effective in reducing the need for exchange transfusion. ...SELECTION CRITERIA: All randomised and quasi-randomised controlled trial …
OBJECTIVES: To assess whether the use of intravenous immunoglobulin, in newborn infants with isoimmune haemolytic jaund …
Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization.
Thomas JT, Muller P, Wilkinson C. Thomas JT, et al. Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD005541. doi: 10.1002/14651858.CD005541.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443599 Free PMC article. Review.
BACKGROUND: Neonates from isoimmunized pregnancies have increased morbidity from neonatal jaundice. ...A recent retrospective case-controlled study showed reduction in the need for exchange transfusion for the neonates from isoimmunized pregnancies. OBJECTIVES: To a …
BACKGROUND: Neonates from isoimmunized pregnancies have increased morbidity from neonatal jaundice. ...A recent retrospective case-co …
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.
Pilgrim H, Lloyd-Jones M, Rees A. Pilgrim H, et al. Health Technol Assess. 2009 Feb;13(10):iii, ix-xi, 1-103. doi: 10.3310/hta13100. Health Technol Assess. 2009. PMID: 19210896 Free article. Review.
CONCLUSIONS: RAADP reduces the incidence of sensitisation and hence of haemolytic disease of the newborn. The economic model suggests that RAADP given to all RhD-negative pregnant women is likely to be cost-effective at a threshold of around 30,000 pounds per …
CONCLUSIONS: RAADP reduces the incidence of sensitisation and hence of haemolytic disease of the newborn. The economic …
13 results